{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:21:16Z","timestamp":1791516076353,"version":"4.3.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF20OC0065767"],"award-info":[{"award-number":["NNF20OC0065767"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008733","name":"Erik H\u00f8rslev and Birgit H\u00f8rslev Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007605","name":"Aarhus Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007605","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002739","name":"Aarhus University Research Foundation","doi-asserted-by":"publisher","award":["AUFF-F-2018-7-2"],"award-info":[{"award-number":["AUFF-F-2018-7-2"]}],"id":[{"id":"10.13039\/501100002739","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejphar.2024.177037","type":"journal-article","created":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T00:48:03Z","timestamp":1728089283000},"page":"177037","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Pharmacological modulation of transglutaminase 2 in the unilateral ureteral obstruction mouse model"],"prefix":"10.1016","volume":"984","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8241-1636","authenticated-orcid":false,"given":"Judit","family":"Prat-Duran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela Bastos Binotti Abreu","family":"De Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Juste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7852-992X","authenticated-orcid":false,"given":"Est\u00e9fano","family":"Pinilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8194-0787","authenticated-orcid":false,"given":"Francisco J.","family":"Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto C.","family":"Montezano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhian M.","family":"Touyz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Simonsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikke","family":"N\u00f8rregaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7972-8181","authenticated-orcid":false,"given":"Niels Henrik","family":"Buus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejphar.2024.177037_bib1","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/S0021-9258(19)75724-X","article-title":"Identification of a guanosine triphosphate-binding site on Guinea pig liver transglutaminase. Role of GTP and calcium ions in modulating activity","volume":"262","author":"Achyuthan","year":"1987","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.ejphar.2024.177037_bib2","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/HJH.0000000000003478","article-title":"Vasoprotective effects of NOX4 are mediated via polymerase and transient receptor potential melastatin 2 cation channels in endothelial cells","volume":"41","author":"Alves-Lopes","year":"2023","journal-title":"J. Hypertens."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177037_bib3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/HYPERTENSIONAHA.119.13861","article-title":"Crosstalk between vascular redox and calcium signaling in hypertension involves TRPM2 (transient receptor potential melastatin 2) cation channel","volume":"75","author":"Alves-Lopes","year":"2020","journal-title":"Hypertension (Dallas, Tex."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177037_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2249.2011.04545.x","article-title":"Transglutaminase 2 expression is enhanced synergistically by interferon-\u03b3 and tumour necrosis factor-\u03b1 in human small intestine","volume":"168","author":"Bayardo","year":"2012","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ejphar.2024.177037_bib5","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cobme.2019.06.003","article-title":"Tissue transglutaminase in fibrosis \u2014 more than an extracellular matrix cross-linker","volume":"10","author":"Benn","year":"2019","journal-title":"Current Opinion in Biomedical Engineering"},{"issue":"January","key":"10.1016\/j.ejphar.2024.177037_bib6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2337\/db12-0293","article-title":"C-Peptide prevents hyperglycemia-induced endothelial apoptosis through inhibition of reactive oxygen species \u2013 mediated transglutaminase 2 activation","volume":"62","author":"Bhatt","year":"2013","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.ejphar.2024.177037_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BSR20160344","article-title":"Differential renal effects of candesartan at high and ultra-high doses in diabetic mice-potential role of the ACE2\/AT2R\/Mas axis","volume":"36","author":"Callera","year":"2016","journal-title":"Biosci. Rep."},{"issue":"4","key":"10.1016\/j.ejphar.2024.177037_bib8","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1021\/bi061787u","article-title":"Kinetic analysis of the interaction of tissue transglutaminase with a nonpeptidic slow-binding inhibitor","volume":"46","author":"Case","year":"2007","journal-title":"Biochemistry"},{"issue":"September","key":"10.1016\/j.ejphar.2024.177037_bib9","article-title":"Withaferin A protects against endoplasmic reticulum stress-associated apoptosis, inflammation, and fibrosis in the kidney of a mouse model of unilateral ureteral obstruction","volume":"79","author":"Chen","year":"2020","journal-title":"Phytomedicine"},{"issue":"7","key":"10.1016\/j.ejphar.2024.177037_bib10","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/cdd.2012.2","article-title":"Type 2 transglutaminase is involved in the autophagy-dependent clearance of ubiquitinated proteins","volume":"19","author":"D'Eletto","year":"2012","journal-title":"Cell Death Differ."},{"issue":"9","key":"10.1016\/j.ejphar.2024.177037_bib11","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1291\/hypres.26.691","article-title":"Candesartan reduces oxidative stress and inflammation in patients with essential hypertension","volume":"26","author":"Dohi","year":"2003","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejphar.2024.177037_bib12","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1681\/ASN.V10102109","article-title":"Effects of transforming growth factor-\u03b21 on renal extracellular matrix components and their regulating proteins","volume":"10","author":"Douthwaite","year":"1999","journal-title":"J. Am. Soc. Nephrol."},{"issue":"7","key":"10.1016\/j.ejphar.2024.177037_bib13","article-title":"The arrive guidelines 2.0: updated guidelines for reporting animal research","volume":"18","author":"du Sert","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ejphar.2024.177037_bib14","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000078639","article-title":"Elevated \u03b5-(\u03b3-glutamyl)lysine in human diabetic nephropathy results from increased expression and cellular release of tissue transglutaminase","volume":"97","author":"El Nahas","year":"2004","journal-title":"Nephron Clin. Pract."},{"key":"10.1016\/j.ejphar.2024.177037_bib15","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/cei.12461","article-title":"Combined C4d and CD3 immunostaining predicts immunoglobulin (Ig)A nephropathy progression","volume":"179","author":"Faria","year":"2015","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177037_bib16","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1681\/ASN.2017050479","article-title":"Proteomic profiling reveals the transglutaminase-2 externalization pathway in kidneys after unilateral ureteric obstruction","volume":"29","author":"Furini","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"issue":"12","key":"10.1016\/j.ejphar.2024.177037_bib17","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1093\/ndt\/gfad118","article-title":"Hypertension in chronic kidney disease - treatment standard 2023","volume":"38","author":"Georgianos","year":"2023","journal-title":"Nephrol. Dial. Transplant."},{"issue":"2 February","key":"10.1016\/j.ejphar.2024.177037_bib18","article-title":"Comparative analysis of hypertensive nephrosclerosis in animal models of hypertension and its relevance to human pathology. Glomerulopathy","volume":"17","author":"Gutsol","year":"2022","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ejphar.2024.177037_bib19","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/01926233231191128","article-title":"Comparative analysis of hypertensive tubulopathy in animal models of hypertension and its relevance to human pathology","volume":"51","author":"Gutsol","year":"2023","journal-title":"Toxicol. Pathol."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177037_bib20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1440-1797.2009.01253.x","article-title":"Additive antifibrotic effects of pioglitazone and candesartan on experimental renal fibrosis in mice","volume":"15","author":"Higashi","year":"2010","journal-title":"Nephrology"},{"issue":"5","key":"10.1016\/j.ejphar.2024.177037_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0298864","article-title":"The effect of TG2-inhibitory monoclonal antibody zampilimab on tissue fibrosis in human in vitro and primate in vivo models of chronic kidney disease","volume":"19","author":"Huang","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2024.177037_bib22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000098646","article-title":"Involvement of transglutaminase-2 in pathological changes in renal disease","volume":"105","author":"Ikee","year":"2007","journal-title":"Nephron Clin. Pract."},{"issue":"4","key":"10.1016\/j.ejphar.2024.177037_bib23","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.febslet.2009.01.032","article-title":"Degradation of transglutaminase 2 by calcium-mediated ubiquitination responding to high oxidative stress","volume":"583","author":"Jeong","year":"2009","journal-title":"FEBS (Fed. Eur. Biochem. Soc.) Lett."},{"issue":"11","key":"10.1016\/j.ejphar.2024.177037_bib24","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1097\/01.TP.0000131171.67671.3C","article-title":"Tissue transglutaminase: a mediator and predictor of chronic allograft nephropathy?","volume":"77","author":"Johnson","year":"2004","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.ejphar.2024.177037_bib25","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1097\/01.ASN.0000079614.63463.DD","article-title":"Tissue transglutaminase and the progression of human renal scarring","volume":"14","author":"Johnson","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177037_bib26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jphs.2017.12.004","article-title":"Role of hypoxia-inducible factor-1 in the development of renal fibrosis in mouse obstructed kidney: special references to HIF-1 dependent gene expression of profibrogenic molecules","volume":"136","author":"Kabei","year":"2018","journal-title":"J. Pharmacol. Sci."},{"issue":"4S","key":"10.1016\/j.ejphar.2024.177037_bib27","first-page":"S117","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2024.177037_bib28","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.bbrc.2010.11.063","article-title":"Transglutaminase 2 gene ablation protects against renal ischemic injury by blocking constant NF-\u03baB activation","volume":"403","author":"Kim","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2024.177037_bib29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0140-6736(13)60473-0","article-title":"Urinary transglutaminase 2 as a potential biomarker of chronic kidney disease detection and progression","volume":"381","author":"Lodge","year":"2013","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ejphar.2024.177037_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/biom9040141","article-title":"Unilateral ureteral obstruction as a model to investigate fibrosis-attenuating treatments","volume":"9","author":"Mart\u00ednez-Klimova","year":"2019","journal-title":"Biomolecules"},{"issue":"11","key":"10.1016\/j.ejphar.2024.177037_bib31","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1007\/s00726-015-2039-5","article-title":"Transglutaminase 2 up-regulation is associated with RANKL\/OPG pathway in cultured HPDL cells and THP-1-differentiated macrophages","volume":"47","author":"Matarese","year":"2015","journal-title":"Amino Acids"},{"issue":"1","key":"10.1016\/j.ejphar.2024.177037_bib32","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-016-0250-6","article-title":"Changes in renal WT-1 expression preceding hypertension development","volume":"17","author":"Mazzei","year":"2016","journal-title":"BMC Nephrol."},{"issue":"25","key":"10.1016\/j.ejphar.2024.177037_bib33","doi-asserted-by":"crossref","first-page":"18108","DOI":"10.1074\/jbc.M607413200","article-title":"Transglutaminase 2 kinase activity facilitates protein kinase A-induced phosphorylation of retinoblastoma protein","volume":"282","author":"Mishra","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.ejphar.2024.177037_bib34","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1074\/jbc.M506864200","article-title":"Phosphorylation of histones by tissue transglutaminase","volume":"281","author":"Mishra","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.ejphar.2024.177037_bib35","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1152\/physrev.00027.2022","article-title":"Obstructive nephropathy and molecular pathophysiology of renal interstitial fibrosis","volume":"103","author":"N\u00f8rregaard","year":"2023","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2024.177037_bib36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1681\/ASN.2012090962","article-title":"Cysteamine modulates oxidative stress and blocks myofibroblast activity in CKD","volume":"25","author":"Okamura","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2024.177037_bib37","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000096981","article-title":"DNA fragmentation in chronic glomerulonephritis: an immunohistological analysis","volume":"105","author":"Ott","year":"2007","journal-title":"Nephron Clin. Pract."},{"key":"10.1016\/j.ejphar.2024.177037_bib38","series-title":"MicroRNA in Regenerative Medicine","first-page":"77","article-title":"Epigenetic modification of MicroRNAs","author":"Pal","year":"2015"},{"issue":"5","key":"10.1016\/j.ejphar.2024.177037_bib39","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1165\/rcmb.2016-0379OC","article-title":"Extracellular matrix cross-linking enhances fibroblast growth and protects against matrix proteolysis in lung fibrosis","volume":"58","author":"Philp","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ejphar.2024.177037_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2020.113608","article-title":"A systematic approach to quantitative Western blot analysis","volume":"593","author":"Pillai-Kastoori","year":"2020","journal-title":"Anal. Biochem."},{"issue":"January","key":"10.1016\/j.ejphar.2024.177037_bib41","first-page":"216","article-title":"Transglutaminase 2 inhibitor LDN 27219 age-dependently lowers blood pressure and improves endothelium-dependent vasodilation in resistance arteries","volume":"77","author":"Pinilla","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2024.177037_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107787","article-title":"Transglutaminase 2 as a novel target in chronic kidney disease \u2013 methods, mechanisms and pharmacological inhibition","volume":"222","author":"Prat-Duran","year":"2021","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.ejphar.2024.177037_bib43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1152\/physiolgenomics.2000.4.1.67","article-title":"Contribution of circulating renin to local synthesis of angiotensin peptides in the heart","volume":"4","author":"Prescott","year":"2000","journal-title":"Physiol. Genom."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177037_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-022-03715-z","article-title":"TRPM7 deficiency exacerbates cardiovascular and renal damage induced by aldosterone-salt","volume":"5","author":"Rios","year":"2022","journal-title":"Commun. Biol."},{"issue":"5","key":"10.1016\/j.ejphar.2024.177037_bib45","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41581-019-0248-y","article-title":"Targeting the progression of chronic kidney disease","volume":"16","author":"Ruiz-Ortega","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"issue":"5","key":"10.1016\/j.ejphar.2024.177037_bib46","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1681\/ASN.2013050563","article-title":"Syndecan-4 knockout leads to reduced extracellular transglutaminase-2 and protects against tubulointerstitial fibrosis","volume":"25","author":"Scarpellini","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"issue":"15","key":"10.1016\/j.ejphar.2024.177037_bib47","doi-asserted-by":"crossref","first-page":"15032","DOI":"10.1074\/jbc.M308734200","article-title":"Cell type-specific activation of intracellular transglutaminase 2 by oxidative stress or ultraviolet irradiation: implications of transglutaminase 2 in age-related cataractogenesis","volume":"279","author":"Shin","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177037_bib48","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2353\/ajpath.2008.080025","article-title":"Tissue transglutaminase contributes to interstitial renal fibrosis by favoring accumulation of fibrillar collagen through TGF-\u03b2 activation and cell infiltration","volume":"173","author":"Shweke","year":"2008","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177037_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-25674-4","article-title":"Isozyme-specific comprehensive characterization of transglutaminase-crosslinked substrates in kidney fibrosis","volume":"8","author":"Tatsukawa","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177037_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22294-x","article-title":"A critical path to producing high quality, reproducible data from quantitative western blot experiments","volume":"12","author":"Taylor","year":"2022","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.ejphar.2024.177037_bib51","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1161\/01.HYP.0000158845.49943.5e","article-title":"Angiotensin II-dependent chronic hypertension and cardiac hypertrophy are unaffected by gp91phox-containing NADPH oxidase","volume":"45","author":"Touyz","year":"2005","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.ejphar.2024.177037_bib52","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00726-004-0094-4","article-title":"Tissue transglutaminase in normal and abnormal wound healing: review article","volume":"26","author":"Verderio","year":"2004","journal-title":"Amino Acids"},{"key":"10.1016\/j.ejphar.2024.177037_bib53","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic kidney disease","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ejphar.2024.177037_bib54","doi-asserted-by":"crossref","first-page":"310","DOI":"10.14701\/ahbps.2018.22.4.310","article-title":"A composite of urinary biomarkers for differentiating between tubulointerstitial inflammation and interstitial fibrosis\/tubular atrophy in kidney allografts","volume":"22","author":"Wee","year":"2018","journal-title":"Annals of Hepato-Biliary-Pancreatic Surgery"},{"issue":"3","key":"10.1016\/j.ejphar.2024.177037_bib55","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2215\/CJN.02390314","article-title":"Mapping novel immunogenic epitopes in IgA nephropathy","volume":"10","author":"Woo","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177037_bib56","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1681\/ASN.2006070770","article-title":"Long-term, high-dosage candesartan suppresses inflammation and injury in chronic kidney disease: nonhemodynamic renal protection","volume":"18","author":"Yu","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177037_bib57","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1046\/j.1471-4159.1998.71010240.x","article-title":"Tissue transglutaminase is an in situ substrate of calpain: regulation of activity","volume":"71","author":"Zhang","year":"1998","journal-title":"J. Neurochem."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924007271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924007271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T01:02:51Z","timestamp":1734570171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924007271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":57,"alternative-id":["S0014299924007271"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177037","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological modulation of transglutaminase 2 in the unilateral ureteral obstruction mouse model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"177037"}}